177lu-lnc1011
PeptideexperimentalImaging agent
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 21, 2023 (NCT06809426)
Timeline
No events for the selected filters.
Mechanism of action
- Glutamate carboxypeptidase IIBINDING AGENT
FOLH1 binding agent
Chemistry & pharmacology
- Imaging
- 177-lutetium
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06250244 | N/A | Oct 1, 2023 | Chinese Academy of Medical Sciences |
| NCT06809426 | N/A | Aug 21, 2023 | Jiangnan University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Chinese Academy of Medical Sciences | Academic/Hospital | 1 | 1 | 1 | 2023 |
| Jiangnan University | Academic/Hospital | 1 | 1 | 1 | 2023 |
2 organizations
Page 1 / 1